PHARMACEUTICAL wholesaler, EBOS Group Limited, believes its TerryWhite Chemmart (TWC) banner will continue to grow as Australia's community pharmacy market consolidates.
In an investor presentation released to the Australian Securities Exchange (ASX) this morning the company said it was "optimistic about the future, with TWC to continue playing an important role in retail pharmacy".
The company noted that "pharmacies will play a wider role in delivering health services across the community" in the future, adding that "biologics represent a new opportunity for the industry, and TWC is well positioned" to support the use of those medications.
EBOS Executive General Manager, David Lewis, told investors that the TWC network grew by more than 100 stores over the last three years, with more than 500 pharmacies now operating across the country.
He said the network would continue to expand by attracting pharmacy owners from rival banner groups and independent stores to join, while also targeting new pharmacies on greenfield sites.
Lewis said that throughout the COVID-19 pandemic the TWC network has generated like-for-like sales growth above the industry average.
He added that three of the key success factors for the TWC brand were its focus on being "experts in care", strengthening its reputation as a trusted provider of prescription and over-the-counter medicines and vaccines, and delivering high network partner satisfaction ratings by generating strong store performance.
Lewis noted that delivering best in class support and training for pharmacists through the TWC Masterclass program and back office systems was a key strategic priority going forward.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Nov 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Nov 22
